Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,4 USD | +9,59% | -0,41% | +56,86% |
Omzet 2024 * | 18,65 mln. 17,29 mln. | Omzet 2025 * | 77,52 mln. 71,85 mln. | Marktkapitalisatie | 591 mln. 548 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -186 mln. -172 mln. | Nettowinst (verlies) 2025 * | -163 mln. -151 mln. | EV/omzet 2024 * | 31,7 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 7,62 x |
K/w-verhouding 2024 * |
-3,38
x | K/w-verhouding 2025 * |
-3,79
x | Werknemers | 285 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,99% |
Recentste transcriptie over Lexicon Pharmaceuticals, Inc.
1 dag | +9,59% | ||
1 week | -0,41% | ||
Lopende maand | -3,61% | ||
1 maand | -8,05% | ||
3 maanden | +56,86% | ||
6 maanden | +118,18% | ||
Lopend jaar | +56,86% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07-07-14 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 01-01-99 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 02-08-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 79 | 01-02-01 |
Ray Debbane
CHM | Chairman | 69 | 01-08-07 |
Director/Board Member | 65 | 28-08-07 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 8 M€ | +9,75% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 2,4 | +9,59% | 7 061 172 |
27-03-24 | 2,19 | +10,61% | 5 170 751 |
26-03-24 | 1,98 | -6,60% | 4 400 437 |
25-03-24 | 2,12 | -6,19% | 4 181 713 |
22-03-24 | 2,26 | -6,22% | 3 254 620 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+56,86% | 591 mln. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-36,53% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |